发明名称 |
INSULIN-LIKE GROWTH FACTOR SIGNALING AND INTEGRIN |
摘要 |
The present invention resides in the discovery that the specific interaction between insulin-like growth factor 1 (IGFl) and integrin is involved in integrin-mediated cellular signaling, such as enhanced proliferation of cells expressing integrin, especially integrin avß3, a6ß1 and a6ß4. Thus, this invention provides for a novel method for inhibiting integrin signaling by using an inhibitor of IGFl -integrin binding. A method for identifying inhibitors of IGFl -integrin binding is also described. Further disclosed are polypeptides, nucleic acids, and corresponding compositions for inhibiting integrin signaling. |
申请公布号 |
WO2010088502(A2) |
申请公布日期 |
2010.08.05 |
申请号 |
WO2010US22561 |
申请日期 |
2010.01.29 |
申请人 |
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA;TAKADA, YOSHIKAZU;SAEGUSA, JUN |
发明人 |
TAKADA, YOSHIKAZU;SAEGUSA, JUN |
分类号 |
A61K39/395 |
主分类号 |
A61K39/395 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|